15 results
8-K
EX-99.1
MYMD
MyMD Pharmaceuticals Inc
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
related to touch in the model of inflammation. This may indicate the potential for fewer side effects compared to traditional opioid pain treatments
424B5
MYMD
MyMD Pharmaceuticals Inc
17 Aug 22
Prospectus supplement for primary offering
3:00pm
to treat various conditions, including, but not limited to, epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid
8-K
EX-99.1
ynxz5
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
425
8eoy4r
13 Apr 21
Business combination disclosure
9:05am
425
jw73dio569gc 2q1enj
12 Apr 21
Business combination disclosure
9:21am
425
yechnk9c
22 Mar 21
Business combination disclosure
5:21pm
425
h9g2fib4542p
18 Feb 21
Business combination disclosure
9:00am
425
hgwdej8km
2 Dec 20
Business combination disclosure
4:59pm
425
98tnlodn
19 Nov 20
Business combination disclosure
8:48am
8-K
EX-99.1
saepl4ii9tu 2ce
18 Nov 20
Other Events
4:52pm
425
EX-99.1
z3swgwdab0x31vf
18 Nov 20
Business combination disclosure
4:50pm
8-K
EX-99.1
9hfimu xag5ojr3
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
- Prev
- 1
- Next